(Q46592717)

23 December 2017

title

Variations in content of active ingredients causing drug interactions in grapefruit juice products sold in California (English)

1 reference

23 December 2017

0 references

Sompon Wanwimolruk

1

1 reference

23 December 2017

Paul V Marquez

series ordinal

2

1 reference

23 December 2017

publication date

1 January 2006

1 reference

23 December 2017

Drug Metabolism and Drug Interactions

published in

1 reference

23 December 2017

volume

21

1 reference

23 December 2017

issue

3-4

1 reference

23 December 2017

page(s)

233-243

1 reference

23 December 2017

Objective measurement of red grapefruit juice color

cites work

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2006.21.3-4.233

The fate of naringin in humans: A key to grapefruit juice-drug interactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2006.21.3-4.233

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2006.21.3-4.233

Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2006.21.3-4.233

6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2006.21.3-4.233

Food-drug interaction: grapefruit juice augments drug bioavailability--mechanism, extent and relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2006.21.3-4.233

Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2006.21.3-4.233

Quantitative survey of narirutin, naringin, hesperidin, and neohesperidin in citrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2006.21.3-4.233

10.1515/DMDI.2006.21.3-4.233

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017